LXEO Lexeo Therapeutics, Inc.
$4.25▼ -2.52%
Healthcare
Other
After hours
$4.25▲ +0.00%
Sep 11, 7:30 PM ET
Volume 1.49M
Avg Volume (10D) 483.0K
Key Metrics & Fundamentals
Market Cap
$348.70M
P/E Ratio
–
Div Yield
–%
52W Range
3.99 - 10.99
% vs 50 MA
-9.97%
% vs 200 MA
-32.57%
RSI-14
36.0
MACD Histogram
-0.0800
Beta (1Y vs SPY)
1.73
Free Cash Flow
-$17.60M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$25.28M
COGS
–
Operating Exp
$28.02M
Operating Income
-$28.02M
EBIT
-$28.02M
Pretax Income
-$25.87M
Net Income
-$25.87M
EPS (Diluted)
-0.30
Price & Volume History
Loading chart…
Recent News
Lexeo Therapeutics to Participate in Upcoming Investor Conferences in September
GlobeNewswire · Sep 2, 2026 11:00 AM
Lexeo Therapeutics Reports Second Quarter 2026 Financial Results and Operational Highlights
GlobeNewswire · Aug 12, 2026 11:00 AM
Lexeo Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for LX2020 for the Treatment of PKP2 Arrhythmogenic Cardiomyopathy
GlobeNewswire · Aug 5, 2026 11:00 AM
What Makes Lexeo Therapeutics (LXEO) One of The Best Stocks Under $10 That Could Triple
Insider Monkey · Jul 15, 2026 3:43 PM
Is Lexeo Therapeutics, Inc. (LXEO) Stock Still a Gene Therapy Opportunity After Analyst Valuation Update?
Insider Monkey · Jul 2, 2026 8:06 PM
Lexeo Therapeutics Announces Publication in JAMA Cardiology of Phase I/II Data for LX2006 in Friedreich Ataxia
GlobeNewswire · Jun 17, 2026 8:01 PM
Lexeo Therapeutics Finalizes Study Design for Friedreich Ataxia Gene Therapy
MT Newswires · Jun 15, 2026 1:29 PM
Lexeo Therapeutics Announces Regulatory Update and Registrational Trial Design for LX2006 Gene Therapy in Friedreich Ataxia
GlobeNewswire · Jun 15, 2026 11:00 AM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See LXEO's money flow as a full page
Social Sentiment
No Reddit posts found for LXEO.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.